Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma.
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
TAS-102 and Anlotinib in ≥3 Lines mGC
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003
- Status
- UNKNOWN
- Phase
- PHASE2
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients
- Status
- COMPLETED
- Phase
- PHASE1
Anlotinib for Esophageal Cancer (AFEC)
- Status
- UNKNOWN
- Phase
- N/A
Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anlotinib for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Fluzopalil in Combination With Anlotinib for Extensive Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase Ⅱ Study of Anlotinib Combined With Tislelizumab and AT in the Neoadjuvant Treatment of Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC
- Status
- COMPLETED
- Phase
- N/A
Furmonertinib Combined With Anlotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
The Efficacy and Safety of Sintilimab Plus Anlotinib Combined With Chemotherapy as Neoadjuvant Therapy in TNBC
- Status
- COMPLETED
- Phase
- PHASE2